Ocugen, Inc. — Director's Dealing 2022

Mar 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2022-03-03

Reporting Person: Zhang Junge (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-03	Common Stock	M	39000	$0.51	Acquired	39000	Direct
2022-03-03	Common Stock	M	49000	$1.83	Acquired	88000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-03	Option (Right to Buy)	$0.51	M	39000	Acquired	2030-01-02	Common Stock (39000)	Direct
2022-03-03	Option (Right to Buy)	$1.83	M	49000	Acquired	2031-01-01	Common Stock (49000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	876904	Indirect

Footnotes

F1: The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal installments over three years commencing on February 2, 2020, subject to continued service with Ocugen, Inc. (the "Company") on the applicable vesting dates.

F2: The options, initially representing a right to purchase 126,000 shares, vest and become exercisable in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates.